{"id":"W2023158584","doi":"10.1182/blood-2014-03-563056","title":"Evolving use of new oral anticoagulants for treatment of venous thromboembolism","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Venous thromboembolism; Medicine; Apixaban; Intensive care medicine; Rivaroxaban; Venous thrombosis; Warfarin; Thrombosis; Surgery; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039125,0.0007178967,0.001362759,0.004243414,0.0003048411,0.00104093,0.0008661938,0.001022625,0.002999844],"category_scores_gemma":[0.001681558,0.0002793393,0.0009760751,0.003472281,0.0005150646,0.001455271,0.0006499552,0.001685905,0.0009784399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008633807,"about_ca_system_score_gemma":0.001689554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001821507,"about_ca_topic_score_gemma":0.00310988,"domain_scores_codex":[0.9993145,0.0001283892,0.0001551879,0.00009184419,0.0002770259,0.0000329954],"domain_scores_gemma":[0.9990975,0.0004754613,0.0001601504,0.00002360001,0.0002080789,0.00003527239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004759822,0.00005467524,0.0003126184,0.05220912,0.0002420489,0.0001905425,0.0001160437,0.0002400016,0.0008882622,0.003807877,0.02363487,0.9182563],"study_design_scores_gemma":[0.00003525494,0.0000924601,0.001828625,0.02380801,0.0004036193,0.002552982,0.0001331179,0.00009265464,0.0003204278,0.001900768,0.9688037,0.00002818967],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006355318,0.9990504,0.00004457717,0.000227625,0.00009456779,0.000003191569,0.000008471307,0.000002982769,0.000504572],"genre_scores_gemma":[0.0003420269,0.9992261,0.0001006898,0.0001352378,0.00007637549,0.000002730959,0.000009639728,5.841638e-7,0.0001066393],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004243414,"threshold_uncertainty_score":0.01003546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1419849776394979,"score_gpt":0.3752387169619204,"score_spread":0.2332537393224225,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}